---
url: https://endpts.com/novo-nordisks-blockbuster-glp-1-products-ozempic-and-wegovy-are-among-the-next-15-drugs-subject-to-the-governments-medicare-negotiation-program-under-the-inflation-reduction-act/?utm_medium=email&amp;utm_campaign=Breaking+Ozempic+among+next+15+drugs+selected+for+IRA+negotiations+Insider&amp;utm_content=Breaking+Ozempic+among+next+15+drugs+selected+for+IRA+negotiations+Insider+CID_c9843463b10225f177c7422ced163153&amp;utm_source=ENDPOINTS+emails&amp;utm_term=Ozemshypic+makes+list+for+next+round+of+Medicare+drug+price+neshygoshytishyashytions
title: "Ozempic makes list for next round of Medicare drug price negotiations"
clipped: 2025-12-23 13:03
source: slack
slack_channel: mkt-research-headlines
---

# Ozempic makes list for next round of Medicare drug price negotiations

> Source: [https://endpts.com/novo-nordisks-blockbuster-glp-1-products-ozempic-and-wegovy-are-among-the-next-15-drugs-subject-to-the-governments-medicare-negotiation-program-under-the-inflation-reduction-act/?utm_medium=email&amp;utm_campaign=Breaking+Ozempic+among+next+15+drugs+selected+for+IRA+negotiations+Insider&amp;utm_content=Breaking+Ozempic+among+next+15+drugs+selected+for+IRA+negotiations+Insider+CID_c9843463b10225f177c7422ced163153&amp;utm_source=ENDPOINTS+emails&amp;utm_term=Ozemshypic+makes+list+for+next+round+of+Medicare+drug+price+neshygoshytishyashytions](https://endpts.com/novo-nordisks-blockbuster-glp-1-products-ozempic-and-wegovy-are-among-the-next-15-drugs-subject-to-the-governments-medicare-negotiation-program-under-the-inflation-reduction-act/?utm_medium=email&amp;utm_campaign=Breaking+Ozempic+among+next+15+drugs+selected+for+IRA+negotiations+Insider&amp;utm_content=Breaking+Ozempic+among+next+15+drugs+selected+for+IRA+negotiations+Insider+CID_c9843463b10225f177c7422ced163153&amp;utm_source=ENDPOINTS+emails&amp;utm_term=Ozemshypic+makes+list+for+next+round+of+Medicare+drug+price+neshygoshytishyashytions)

![](https://endpoints.news/wp-content/uploads/2024/08/shutterstock_2495192361-scaled.jpg)

Image: Shutterstock

January 17, 2025 08:05 AM ESTUpdated 08:42 AM

[Pharma](https://endpoints.news/channel/pharma/ "Channel: Pharma")

# Ozem­pic makes list for next round of Medicare drug price ne­go­ti­a­tions

### [Nicole DeFeudis](https://endpoints.news/author/nicole-defeudis/ "See all stories by Nicole DeFeudis")

#### Senior Reporter

No­vo Nordisk’s block­buster GLP-1 prod­ucts Ozem­pic and We­govyare among the next 15 drugs sub­ject to the gov­ern­ment’s Medicare ne­go­ti­a­tion pro­gram un­der the In­fla­tion Re­duc­tion …

![Endpoints News](https://endpoints.news/wp-content/themes/endpoints-rakia/assets/svg/epn_logo.svg)

### Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

[SIGN UP](https://profile.endpoints.news/sso?mode=sign-up&r=https%3A%2F%2Fendpoints.news%2Fauth&a%5Bt%5D=L25vdm8tbm9yZGlza3MtYmxvY2tidXN0ZXItZ2xwLTEtcHJvZHVjdHMtb3plbXBpYy1hbmQtd2Vnb3Z5LWFyZS1hbW9uZy10aGUtbmV4dC0xNS1kcnVncy1zdWJqZWN0LXRvLXRoZS1nb3Zlcm5tZW50cy1tZWRpY2FyZS1uZWdvdGlhdGlvbi1wcm9ncmFtLXVuZGVyLXRoZS1pbmZsYXRpb24tcmVkdWN0aW9uLWFjdC8%2FdXRtX21lZGl1bT1lbWFpbCZhbXA7dXRtX2NhbXBhaWduPUJyZWFraW5nK096ZW1waWMrYW1vbmcrbmV4dCsxNStkcnVncytzZWxlY3RlZCtmb3IrSVJBK25lZ290aWF0aW9ucytJbnNpZGVyJmFtcDt1dG1fY29udGVudD1CcmVha2luZytPemVtcGljK2Ftb25nK25leHQrMTUrZHJ1Z3Mrc2VsZWN0ZWQrZm9yK0lSQStuZWdvdGlhdGlvbnMrSW5zaWRlcitDSURfYzk4NDM0NjNiMTAyMjVmMTc3Yzc0MjJjZWQxNjMxNTMmYW1wO3V0bV9zb3VyY2U9RU5EUE9JTlRTK2VtYWlscyZhbXA7dXRtX3Rlcm09T3plbXNoeXBpYyttYWtlcytsaXN0K2ZvcituZXh0K3JvdW5kK29mK01lZGljYXJlK2RydWcrcHJpY2UrbmVzaHlnb3NoeXRpc2h5YXNoeXRpb25z)
[LOG IN](https://profile.endpoints.news/sso?r=https%3A%2F%2Fendpoints.news%2Fauth&a%5Bt%5D=L25vdm8tbm9yZGlza3MtYmxvY2tidXN0ZXItZ2xwLTEtcHJvZHVjdHMtb3plbXBpYy1hbmQtd2Vnb3Z5LWFyZS1hbW9uZy10aGUtbmV4dC0xNS1kcnVncy1zdWJqZWN0LXRvLXRoZS1nb3Zlcm5tZW50cy1tZWRpY2FyZS1uZWdvdGlhdGlvbi1wcm9ncmFtLXVuZGVyLXRoZS1pbmZsYXRpb24tcmVkdWN0aW9uLWFjdC8%2FdXRtX21lZGl1bT1lbWFpbCZhbXA7dXRtX2NhbXBhaWduPUJyZWFraW5nK096ZW1waWMrYW1vbmcrbmV4dCsxNStkcnVncytzZWxlY3RlZCtmb3IrSVJBK25lZ290aWF0aW9ucytJbnNpZGVyJmFtcDt1dG1fY29udGVudD1CcmVha2luZytPemVtcGljK2Ftb25nK25leHQrMTUrZHJ1Z3Mrc2VsZWN0ZWQrZm9yK0lSQStuZWdvdGlhdGlvbnMrSW5zaWRlcitDSURfYzk4NDM0NjNiMTAyMjVmMTc3Yzc0MjJjZWQxNjMxNTMmYW1wO3V0bV9zb3VyY2U9RU5EUE9JTlRTK2VtYWlscyZhbXA7dXRtX3Rlcm09T3plbXNoeXBpYyttYWtlcytsaXN0K2ZvcituZXh0K3JvdW5kK29mK01lZGljYXJlK2RydWcrcHJpY2UrbmVzaHlnb3NoeXRpc2h5YXNoeXRpb25z)
[BECOME A PREMIUM SUBSCRIBER](https://profile.endpoints.news/upgrade)